Targeted cancer therapy. That’s what “precision oncology” is all about.
The approach is based on the specific genes and proteins within a tumor. Increasingly, doctors are able to choose drugs that target those individual biological signatures. The result is more effective treatment.
Veterans and others can learn more about what VA is doing in this area by attending an upcoming lecture, online or in person.
On Monday, Feb. 24, 1 –2:30 p.m. EST, VA’s Office of Research and Development is sponsoring a presentation at VA headquarters by oncologist Dr. Bruce Montgomery. The title is “Precision Oncology for Veterans with Prostate Cancer: Who, What, How, and Why.”
Montgomery is the co-lead for the Precision Oncology Program for Cancer of the Prostate. The program is a partnership between VA and the Prostate Cancer Foundation.
Montgomery says the work promises to have a wide impact, in VA and beyond.
“The whole idea behind this effort was to stand up an integrated precision oncology system in VA and show that if we can do this in the biggest health care system in the U.S., then the optimal efficiency and outcomes can be extended outside of VA and provide better results for everybody.”
Talk geared for lay people
His talk Feb. 24 will be geared for lay people, including VA patients and employees. Montgomery will cover the program’s mission, goals and progress. The aim is to inform VA staff, external partners, Veterans, and the public about the steps VA is taking to better treat metastatic prostate cancer. “Metastatic” refers to cancer that has spread in the body.
Join in person at 810 Vermont Ave. N.W., Washington, D.C., in the Sonny Montgomery Conference Room (230), or online. People should pre-register at www.research.va.gov/events. The website has a link to attend the lecture online, as well as instructions for those who plan to attend in person.
To read more about the VA-Prostate Cancer Foundation partnership focused on Veterans with prostate cancer, visit the VA research website.
Photo: Dr. Bruce Montgomery meets with Navy Veteran Allen Petchnick, whose prostate cancer has been effectively treated to date with targeted therapy. (Photo by Christopher Pacheco)